MaaT Pharma: Advancing a pipeline of novel microbiome therapies across oncology
Why IDO1 inhibitors fell short in cancer immunotherapy — and what comes next for tryptophan targeting
Cancer type: Hematologic
Hematologic (leukemia, lymphoma, myeloma)